Cargando…

Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication

Siglec-9 is an MHC-independent inhibitory receptor selectively expressed on CD56(dim) NK cells. Its role in infection diseases has not been investigated yet. Here, we studied the potential regulatory roles of NK Siglec-9 in the pathogenesis of chronic hepatitis B (CHB) infection. Flow cytometry eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Di, Jiang, Xuemei, Xu, Yong, Yang, Huimin, Gao, Dongni, Li, Xueen, Gao, Lifen, Ma, Chunhong, Liang, Xiaohong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988867/ https://www.ncbi.nlm.nih.gov/pubmed/29899741 http://dx.doi.org/10.3389/fimmu.2018.01124

Ejemplares similares

The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression
por: Zheng, Yayun, et al.
Publicado: (2020)

Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans
por: Rosenstock, Philip, et al.
Publicado: (2017)

Tim‐3 blockade promotes iNKT cell function to inhibit HBV replication
por: Xu, Yong, et al.
Publicado: (2018)

CUL4B facilitates HBV replication by promoting HBx stabilization
por: Shan, Haixia, et al.
Publicado: (2022)

Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells
por: Adeniji, Opeyemi S., et al.
Publicado: (2021)

Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2
por: Saini, Pratima, et al.
Publicado: (2023)

CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition
por: Pan, Yingfang, et al.
Publicado: (2015)

NKG2C(+) natural killer cell function improves the control of HBV replication in individuals with acute HIV infection coinfected with HBV
por: Song, Ting, et al.
Publicado: (2020)

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021)

HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma
por: Liu, Peng, et al.
Publicado: (2015)

Comparison of (68)Ga-DOTA-Siglec-9 and (18)F-Fluorodeoxyribose-Siglec-9: Inflammation Imaging and Radiation Dosimetry
por: Virtanen, Helena, et al.
Publicado: (2017)

Hepatitis C Virus and Human Cytomegalovirus—Natural Killer Cell Subsets in Persistent Viral Infections
por: Pollmann, Julia, et al.
Publicado: (2017)

Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients
por: Benmerzoug, Sulayman, et al.
Publicado: (2021)

Siglec-9(+) tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer
por: Wang, Yiying, et al.
Publicado: (2023)

cccDNA Surrogate MC-HBV–Based Screen Identifies Cohesin Complex as a Novel HBV Restriction Factor
por: Wu, Zhuanchang, et al.
Publicado: (2022)

Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells
por: Zhao, Songbo, et al.
Publicado: (2021)

Development of Effective Siglec-9 Antibodies Against Cancer
por: Wang, Jun Hui Shawn, et al.
Publicado: (2022)

Characterization of tumor infiltrating Natural Killer cell subset
por: Levi, Inbar, et al.
Publicado: (2015)

Siglec Ligands
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2021)

Suppression of HBV replication by the expression of nickase- and nuclease dead-Cas9
por: Kurihara, Takeshi, et al.
Publicado: (2017)

Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9
por: Chan, Chilam, et al.
Publicado: (2023)

Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017)

Frequency and phenotype of natural killer cells and natural killer cell subsets in bovine lymphoid compartments and blood
por: Hamilton, Carly A., et al.
Publicado: (2017)

Increased expression of Siglec-9 in chronic obstructive pulmonary disease
por: Zeng, Zhilin, et al.
Publicado: (2017)

Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer
por: Daly, John, et al.
Publicado: (2019)

Liver natural killer cells: subsets and roles in liver immunity
por: Peng, Hui, et al.
Publicado: (2016)

Impaired natural killer cell subset phenotypes in human obesity
por: Bähr, Ina, et al.
Publicado: (2018)

Role of Distinct Natural Killer Cell Subsets in Anticancer Response
por: Stabile, Helena, et al.
Publicado: (2017)

Coevolution of Siglec-11 and Siglec-16 via gene conversion in primates
por: Hayakawa, Toshiyuki, et al.
Publicado: (2017)

Early life gut microbiota sustains liver-resident natural killer cells maturation via the butyrate-IL-18 axis
por: Tian, Panpan, et al.
Publicado: (2023)

Defective natural killer cell anti-viral capacity in paediatric HBV infection
por: Heiberg, I L, et al.
Publicado: (2015)

Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity
por: Choi, Hyeree, et al.
Publicado: (2021)

Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication
por: Zhong, L, et al.
Publicado: (2015)

NCR1 Expression Identifies Canine Natural Killer Cell Subsets with Phenotypic Similarity to Human Natural Killer Cells
por: Foltz, Jennifer A., et al.
Publicado: (2016)

Effector Functions of Natural Killer Cell Subsets in the Control of Hematological Malignancies
por: Gismondi, Angela, et al.
Publicado: (2015)

The Diagnostic Utility of Natural Killer Cell Subsets in Deep Vein Thrombosis
por: Alhabibi, Alshaymaa M, et al.
Publicado: (2023)

Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types
por: Wu, Yuliang, et al.
Publicado: (2022)

The Frequency of Natural Killer Cell Subsets in Patients with Acquired Immune Deficiency Syndrome with Deep Fungal Infections
por: Chen, Gao, et al.
Publicado: (2021)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022)

Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals
por: Lee, Z., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ooch7h24mo9r4cj2otkdb6ekl4